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http://www.biomedcentral.com/1471-2350/15/35CASE REPORT Open AccessDe novo SCN2A splice site mutation in a boy with
Autism spectrum disorder
Teresa Tavassoli1,2*, Alexander Kolevzon1,2,3,7, A Ting Wang1,2,5,6, Jocelyn Curchack-Lichtin1,2, Danielle Halpern1,
Lily Schwartz1, Sarah Soffes1, Lauren Bush1, David Grodberg1,2, Guiqing Cai4 and Joseph D Buxbaum1,2,4,5,6,7Abstract
Background: SCN2A is a gene that codes for the alpha subunit of voltage-gated, type II sodium channels, and is
highly expressed in the brain. Sodium channel disruptions, such as mutations in SCN2A, may play an important role
in psychiatric disorders. Recently, de novo SCN2A mutations in autism spectrum disorder (ASD) have been identified.
The current study characterizes a de novo splice site mutation in SCN2A that alters mRNA and protein products.
Case presentation: We describe results from clinical and genetic characterizations of a seven-year-old boy with
ASD. Psychiatric interview and gold standard autism diagnostic instruments (ADOS and ADI-R) were used to confirm
ASD diagnosis, in addition to performing standardized cognitive and adaptive functioning assessments (Leiter-R and
Vineland Adaptive Behavior Scale), and sensory reactivity assessments (Sensory Profile and Sensory Processing
Scales). Genetic testing by whole exome sequencing revealed four de novo events, including a splice site mutation
c.476 + 1G > A in SCN2A, a missense mutation (c.2263G > A) causing a p.V755I change in the TLE1 gene, and two
synonymous mutations (c.2943A > G in the BUB1 gene, and c.1254 T > A in C10orf68 gene). The de novo SCN2A
splice site mutation produced a stop codon 10 amino acids downstream, possibly resulting in a truncated protein
and/or a nonsense-mediated mRNA decay. The participant met new DSM-5 criteria for ASD, presenting with social
and communication impairment, repetitive behaviors, and sensory reactivity issues. The participant’s adaptive and
cognitive skills fell in the low range of functioning.
Conclusion: This report indicates that a splice site mutation in SCN2A might be contributing to the risk of ASD.
Describing the specific phenotype associated with SCN2A mutations might help to reduce heterogeneity seen in
ASD.
Keywords: DSM-5, autism spectrum disorder, de novo SCN2A splice site mutationBackground
Autism spectrum disorders (ASDs) are a group of neu-
rodevelopmental disorders characterized by social and
communication impairments, repetitive behaviors, and sen-
sory reactivity issues [1]. The etiology of ASD is genetically
heterogeneous and de novo mutations and copy number
variations account for 15-20% of ASD cases [2]. Recently,
Sanders et al. [14] and Neale et al. [3] reported de novo
SCN2A mutations (which codes for the alpha subunit of
voltage-gated, type II sodium channel) in three cases with
ASD, one of which [3] will be described in detail herein.* Correspondence: teresa.tavassoli@mssm.edu
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unless otherwise stated.SCN2A is involved in generating action potentials in
neurons and muscles and is highly expressed in the
brain, specifically in neurons and glia [4]. A recent paper
highlights the role of sodium channels in psychiatric dis-
orders and neurological diseases [4]. Sodium-channel
disruption, caused by mutations on SCN2A and related
genes such as SCN1A or SCN9A, has been associated
with ASD, intellectual disability, ataxia and increased
sensitivity to pain [5-8]. SCN2A mutations have also
been associated with various forms of epilepsy [9-12]. A
case report documented seizures in a participant with
SCN2A mutation, along with abnormal visual fixation
and poor muscle tone [13]. However, not all patients
with SCN2A mutations have been reported to have epi-
lepsy [14,15].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Domains and measures used in the current study
Domain Measure
Genetic testing
WES
CMA
Clinical assessment
Neurological examination Clinical genetics; height, weight,
dysmorphic features
Autism spectrum disorder (ASD) traits ADOS
ADI-R
Cognitive and adaptive behavior skills Leiter-R
Vineland Adaptive Behavior Scale
Sensory reactivity Sensory Profile
Sensory Over-Responsivity Scale
Brain development
Structural Imaging MRI
Abbreviations: CMA = chromosomal microarray analysis; WES = whole exome
sequencing; ADOS = Autism Diagnostic Observation Schedule; ADI-R = Autism
Diagnostic Interview Revised; MRI = Magnetic Resonance Imaging.
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site mutation in SCN2A that alters mRNA. We used
gold standard autism diagnostic instruments, structured
clinical interview, standardized cognitive testing, and
sensory reactivity assessments to probe for diagnostic
status, cognitive and adaptive functioning, and sensory
reactivity, including hyper-reactivity to stimuli in the en-
vironment. Describing phenotypes of SCN2A cases will
eventually help to reduce the phenotypic heterogeneity
seen in individuals with ASD.
Case presentation
Methods
The participant was ascertained as part of ongoing
IRB-approved genetic research in ASD at the Seaver
Autism Center for Research and Treatment at the Icahn
School of Medicine at Mount Sinai. Genetic testing
included chromosomal microarray analysis (CMA)
(Agilent Human CGH 1 × 244A, Agilent Technologies,
Santa Clara, CA) and whole exome sequencing (WES).
Clinical assessments included: (1) neurological examin-
ation conducted by a pediatric neurologist; (2) psychi-
atric evaluation using the DSM [16] conducted by a
board-certified child and adolescent psychiatrist; (3) the
Autism Diagnostic Observation Schedule (ADOS) [17];
(4) the Autism Diagnostic Interview Revised (ADI-R);
(5) cognitive testing using the Leiter International Per-
formance Scale-Revised [18]; (6) adaptive ratings using
the Vineland Adaptive Behavior Scales-II, Survey Edition
[19]; and (7) tests of sensory reactivity, including the
Caregiver Sensory Profile, a 125-item questionnaire [20]
and the Sensory Processing Scales [21]. Magnetic Reson-
ance Imaging (MRI) was conducted to check for struc-
tural brain abnormalities (Table 1).
Genetic testing
Whole exome sequencing
High quality genomic DNA from peripheral blood of the
participant and both parents were used for library prep-
aration. A total of 3 ug DNA were sheared separately
with a Covaris Acoustic Disruptor (E210) instrument set
to time 250 sec, duty cycle 10, intensity 10 and 200 cycles
per burst. The size distribution of fragments was cen-
tered about 200 bp and verified by Agilent Bioalayzer.
NEBNext™ DNA Sample Prep Master Mix Set 1 (New
England BioLabs) was used for creating the DNA library.
During the adaptor ligation, a six-base sequence index
was introduced into the adapter for multiplex sequen-
cing on the Illumina platform.
NimbleGen Seq Cap EZ SR v2 kit (Roche NimbleGen)
was used for whole exome library preparation using stand-
ard protocol. Prepared libraries were then sequenced with
the Hiseq 2000 - V2.5 flowcells. The standard Illumina
software was used for de-multiplexing.Sequencing data was processed with Picard (http://
picard.sourceforge.net/), which utilizes base quality-score
recalibration and BWA for mapping reads to hg19. Gen-
etic variants were called using GATK and were annotated
by AnnTools (http://anntools.sourceforge.net/). Potential
de novo mutation was defined as a heterozygous genotype
in the participant and observed reference homozygote ge-
notypes in both parents and in the absence of any other
copy of the alternate allele. Each putative de novo event
was validated in the participant and both parents using
the Sanger sequencing method.RT-PCR and cDNA sequencing in lymphoblastoid cell lines
Lymphoblastoid cell lines from the participant and par-
ents were cultured and used to isolate total RNA using
the RNeasy Mini kit (Qiagen). SuperScript® II reverse
transcriptase and random primers (Life Technology)
were used to generate cDNA from the RNA. Different
pairs of primer from exon 2 to exon 6 were designed to
amplify wildtype and mis-spliced cDNA.Clinical assessments
Autism spectrum disorder (ASD) traits
The Autism Mental Status Exam (AMSE) was used to
structure the direct observation of the subject during the
clinical evaluation and was performed by a child and ado-
lescent psychiatrist with expertise in ASD [22]. The
ADOS, Module 1, was administered at age three and again
at age seven. The ADI-R was conducted with the mother
when the participant was three years old [23].
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The Leiter-R relies on nonverbal instructions for admin-
istration, requires minimal motor skills, and measures
only nonverbal elements of cognitive functioning [18].
Ratio IQs were calculated using mental age estimates
from the cognitive tests and used to provide an estimate
of nonverbal IQ. The Vineland Adaptive Behavior Scale
was used to measure communication, daily living skills,
socialization and motor skills [19].
Sensory assessment
The Sensory Profile is a validated instrument, which was
standardized using a sample of over 1000 typical devel-
oping children [20]. The Sensory Profile is a 125-item
questionnaire that has identified sensory differences in
over 90% of children and adults with ASD, compared to
controls [24-31] and was used to query parents about
the frequency (1 = always; 5 = never) of sensory behaviors
such as, ‘avoids going barefoot, especially in sand or
grass (item 3). The parents also filled out the Sensory
Processing Scale (SP Scale) [21,32], which includes 60
items for Sensory Over-Responsivity (SOR) (These smells
bother my child, e.g. soap) and 30 items for Sensory
Under-Responsivity (Typically my child does not notice
e.g. strong odors). Unlike other scales, the SP Scale re-
flects sensory processing across all sensory domains
(tactile, visual, olfactory, auditory, vestibular, propriocep-
tion and gustatory). Parents complete the Inventories by
scoring each item as a “1” if the behavior describes their
child. Total scores are then computed for each subtype.
Results
Whole exome sequencing results
The participant first presented to the Seaver Autism
Center for Research and Treatment at Mount Sinai for
evaluation at the age of three. At that time, chromosome
microarray was performed and no pathogenic alterations
were detected. Follow-up testing using whole exome se-
quencing subsequently identified the SCN2A mutation,
and the participant returned for another clinical assess-
ment at age seven.
A total of four de novo events were identified by whole
exome sequencing, including a splice site mutation
c.476 + 1G >A in SCN2A, a missense mutation (c.2263G >
A) causing a p.V755I change in the TLE1 gene, and two
synonymous mutations (c.2943A >G in the BUB1 gene,
and c.1254 T >A in C10orf68 gene). All of the four de
novo mutations were heterozygous mutations and none
have been reported in the dbSNP or other genomic da-
tabases. We validated each mutation and its de novo
status by Sanger sequencing in the participant and par-
ental DNA.
The SCN2A splice site mutation was in the donor site of
intron 4 of the longest isoform (NM_021007) of SCN2A.This exon is conserved in two other isoforms (NM_
001040142 and NM_001040143) of the gene as reported
in the Refseq gene database.
Since the splice site mutation could affect mRNA spli-
cing, we further examined cDNA of SCN2A in cell lines
from the participant and parents (see Figure 1). cDNA
sequencing showed both exon 3 and exon 4 were spliced
out in the participant, while it is expressed normally in
the parents. The mis-splicing caused 209 nt deletion in
the mRNA and altered the reading frame of the mRNA
starting with amino acid 90. It produced a stop codon
10 amino acids downstream, possibly resulting in a trun-
cated protein and/or a nonsense-mediated mRNA decay.
Clinical assessments
Neurological and clinical genetic examinations
The participant’s height was 136 cm at age seven years
and nine months (75th percentile), his weight was 32.8 kg
(82nd percentile) and his head circumference was 52.2 cm
(50th percentile). The participant showed some mild dys-
morphic features, including eye asymmetry, fleshy ear-
lobes, and a gap between front teeth. On a cardiovascular
exam, the participant had regular heart rate and rhythm,
and no murmur was apparent. Motor examination re-
vealed mild hypotonia, but normal strength. Deep tendon
reflexes and extensor signs were tested but difficult to
elicit. There was no clonus. The participant exhibited a
broad-based, abnormal gait with some waddling. He was
unsteady standing or walking on uneven surfaces. How-
ever there were no abnormal movements. Cranial nerve
examination was normal and visual fields were full. Sen-
sory examination elicited symmetrical responses to touch
and pain.
Psychiatric evaluation
The participant’s parents reported longstanding impair-
ment in social and communicative functioning. His par-
ents reported that his receptive language skills were
more advanced than his expressive language. There was
no report of delayed or immediate echolalia but there
was report of intermittent vocal stereotypy. The partici-
pant did not exhibit the capacity for oral motor imita-
tion skills. In the behavioral domain, the participant
demonstrated repetitive, compulsive-like behaviors, in-
cluding repetitive opening and closing of doors. Motor
stereotypies were characterized by arm flapping. Encom-
passing pre-occupations were reported as specific pre-
occupations with toys that emit noise.
The participant also had a low frustration tolerance
and displayed intermittent tantrum behaviors, which in
their severest form included banging his head with his
arms and fists. With regard to adaptive functioning, the
participant was not consistently bladder trained at night
and was not bowel trained during the day. With regard
Figure 1 A de novo SCN2A splice mutation in a participant with ASD. (A) The de novo splice mutation c.476 + 1G > A is in the donor site of
intron 4, which is conserved over three transcripts of SCN2A gene. (B) cDNA sequencing in the lymphoblastoid cell lines shows both exon 3 and
exon 4 were spliced out in the participant, likely resulting in a truncated short protein.
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pain threshold, and he did not tolerate certain types of
touch (e.g. getting a haircut). The participant was de-
scribed as a picky eater.
As for medical history, the parents reported no history
of seizures. However, in the first year of life there were
frequent episodes of becoming “stone faced” and “limp”.
Pregnancy and birth were normal. Parents were both in
their mid-thirties when the participant was born. There
was no family history of ASD, language delay, intellec-
tual disability or Attention Deficit/Hyperactivity Disorder.
Family history was positive for Obsessive Compulsive
Disorder.
Regarding developmental history, the participant had
motor delays; he did not sit or crawl and only began
walking at approximately two years of age. The partici-
pant had longstanding language impairment and had
only begun using single words at age 4, after beginning
Applied Behavioral Analysis (ABA). There was no report
of loss of skills. As for educational history the participantwas referred for early intervention services at 18 months
due to concerns about motor and language delays at
which time he began receiving occupational therapy
(OT) and physical therapy (PT).
Autism spectrum disorder diagnostic test
Mental status exam The participant showed significant
social impairment and was unable to engage in joint at-
tention or social reciprocity on examination. Although
he was able to make fleeting eye contact, he was unable
to point or follow pointing. Further, the participant
showed motor stereotypies such as hand flapping and
engaged in compulsive opening and closing of doors.
ADOS Overall, the participant’s scores were consistent
with a classification of autism in the areas of communi-
cation, reciprocal social interactions and repetitive be-
haviors, and in total at age three and at age seven. As for
communication, at age seven the participant directed vo-
calizations towards the examiner infrequently and used
Table 2 Leiter International Performance Scale scores at
ages three and seven
Subtest Scaled score at age
3 years 9 month
Scales score at age
7 years and 9 month
Visualization
Figure ground 4 1
Matching 5 1
Picture context 4 -
Paper folding - 2
Form completion 5 1
Reasoning
Classification 2 -
Sequential order 3 5
Design analogies - 5
Repeated patterns 4 1
Table 3 Summary of Vineland Adaptive Behavior Scale
results
Vineland Adaptive
Behavior Scale
SCN2A case Compared to
normative scores
Adaptive behavior composite 64 1st percentile, low range
Communication 35 8th percentile, low range
Daily living skills 25 1st percentile, low range
Socialization 30 3rd percentile, low range
Motor skills 17 1st percentile, low range
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the purpose of requesting (e.g. “Go bathroom”). The in-
tonation of his speech tended either to be flat or to take
on a “sing-song” quality. With respect to nonverbal
communication, he did not point or use any other com-
mon gestures throughout the assessment (e.g., head nod-
ding, shrugging).
As for the social domain, the participant demonstrated
several emerging social skills, including the ability to re-
spond to his name as well as bids for joint attention.
However, eye contact and social responsiveness were in-
consistent throughout the observation.
Regarding repetitive and stereotyped behaviors, the
participant demonstrated sensory interests and hand
mannerisms, such as touching the length of his index
finger to his mouth and flapping his hands, respectively.
ADI-R The participant met criteria for autism in all three
diagnostic domains (Qualitative Abnormalities in Recipro-
cal Social Interaction, Qualitative Abnormalities in Com-
munication, and Restricted, Repetitive and Stereotyped
Patterns of Behavior) as reported by his mother.
According to his mother’s report, the participant was
generally unresponsive to unfamiliar people, but he was
responsive to familiar individuals, smiled, and displayed
a range of appropriate facial expressions. Language was
described as limited to two-word phrases, and beyond
shaking his head or occasionally nodding, he did not use
nonverbal gestures. Finally, the participant displayed ex-
cessive interest in books, prompting his parents to carry
a book with them everywhere; he was reported to line
up his toys, tended to focus on part of his toys rather
than the whole toy, and was particularly drawn to visual
reflections.
Cognitive and adaptive evaluations
Leiter international performance subscales
At age three years and nine months, the participant’s
Full Scale IQ was estimated to be 53, which falls into the
extremely low range of functioning. At age seven years
and nine months, the estimated Full Scale IQ was 45,
which falls in the extremely low range as well. This ap-
parent decline in IQ between the ages of three and seven
is unlikely to be related to loss of skills but instead due
to the lack of appropriate gains as compared to typically
developing peers. The participant had difficulty attend-
ing to tasks and could not complete all subtests. A rela-
tive strength was the participant’s ability to match basic
visual-perceptual stimuli (see Table 2).
Adaptive behavior
The participant had an overall adaptive behavior com-
posite score and sub scores in the low to moderately low
range (see Table 3).Sensory assessment
Sensory profile
The participant presented with sensory reactivity abnor-
malities as reported by his parents on the widely used
Sensory Profile. Definite differences were reported (2
standard deviations above the mean) on oral, tactile,
multisensory and vestibular processing. Probable differ-
ences (one standard deviation above from mean) were
reported on auditory processing (see Table 4). In terms
of sensory modulation, definite differences were shown
on sensory processing related to endurance/tone, modu-
lation of movement affecting activity level, and modula-
tion of sensory input affecting emotional response. On
the Factors of the Sensory Profile, the participant
showed definite differences on all factors other than sen-
sory sensitivity, which was in the typical range. Re-
sponses on all other factors including sensory seeking,
poor registration, low endurance, fine motor, sedentary
and distractibility showed definite differences as com-
pared to typically developing children. Taken together
the participant shows severe sensory reactivity issues.
Sensory over-responsivity inventory
The parents endorsed 35% of the items (21 out of 60) on
the Sensory Over-Responsivity Scale (see Table 5). The
Table 4 Summary of the participant’s sensory profile scores
Sensory processing SCN2A case Typical performance Probable difference Definite difference
Oral sensory processing 25 55-48 47-45 44-11
Touch processing 59 90-73 72-65 64-18
Multisensory processing 19 35-27 26-24 23- 7
Vestibular processing 43 55-48 47-45 44-11
Visual processing 26 45-32 31-27 26-9
Auditory processing 26 40-30 29-26 25-8
The classifications of typical, probable and definite differences were based on the performance of children without disabilities (n = 1,037, see Dunn, 1997).
Probable differences are characterized as being over 2 standard deviations away from norm and definite differences as being over 3 standard deviations away
from norm.
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sensory over-responsive. Specifically, tactile accessories
(scarf, hat etc.), fuzzy or furry textures, wool clothes,
washing or wiping face, cutting nails, having hair cut,
and light stroking of the skin bother the participant. In
terms of vision, brightly color material, fluorescent light,
visually cluttered environments, and busy pictures both-
ered the participant. In terms of sound, small motor
noises, restaurants and large gatherings bothered the
participant. In addition, the parents endorsed 14 out of
31 items on the Sensory Under Responsivity Inventory.
Parents reported that the participant responds less than
others to bruises or cuts, hurting himself, dirtying him-
self, and bumping into things. In addition, the partici-
pant does not notice when his hands or face are messy/
dirty, when he needs to use the toilet, or if an object
cames close to his eyes.
Brain development
MRI
A brain MRI was performed using a Siemens Allegra 3 T
head-only scanner. The research protocol on the diagnos-
tic images showed no evidence of infra or supratentorial
masses. The lateral ventricles appeared normal. No mid-
line shift was appreciated and the ventricles and sulci were
within normal limits. No white matter abnormalities were
appreciated. The flow voids in the vessels appeared grossly
within normal limits. The overall impression showed a
normal research protocol of the brain.
Conclusions
The current study describes a 7-year-old boy with a de
novo SCN2A splice site mutation (c.476 + 1G >A). Al-
though this particular mutation has not been reportedTable 5 Participants scores on the sensory over- responsivity
Sensory processing SCN2A score Typical pe
Sensory over-reactivity 21 4 ± 4.7
Scores for typically developing participant’s and participants with sensory difficultiebefore, it could be considered as contributing to risk of
ASD by causing abnormal gene splicing, leading to signifi-
cantly shortened protein product and/or an abnormal
message that is subject to nonsense-mediated mRNA
decay. The participant also presented with three other de
novo events, one missense mutation in TLE1 gene, and
two synonymous mutations in BUB1 gene. While the four
de novo mutations support the notion of multiple hits in
ASD, the de novo SCN2A splice site mutation, a recently
identified ASD gene, is likely to be driving the severity of
symptoms. The participant presented with ASD as diag-
nosed using psychiatric evaluation and confirmed by
the ADOS and ADI-R. The participant showed social
and communication problems, repetitive behaviors and
sensory over- and under-reactivity. Neurological and
clinical genetic examinations revealed hypotonia, ab-
normal gait and fine motor coordination, and mild dys-
morphic features. Further, the participant’s adaptive
and cognitive skills fell in the low range of functioning.
No structural brain abnormalities were evident on MRI,
which is consistent with past reviews of participants
with sodium channel disruptions [11].
Interestingly, the participant does not have any history
of seizures. Participants with SCN2A mutations have
been identified with seizures and various forms of epi-
lepsy [15]. However, in the current case, no seizures
were observed. Although electroencephalography was
attempted, the participant’s sensory reactivity issues pre-
vented any usable data from being recorded. The ab-
sence of seizures is consistent with a recent study by
Sanders et al. (2012), which reported two de novo
SCN2A cases that did not show any history of seizures
[14]. However, in our study it was noted that there were
frequent episodes of becoming “stone faced” and “limp”scale
rformance Children with sensory processing difficulties
18.5 ± 13.9
s were taken from Schoen, et al. 2008 [32].
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seizure activity. On the other hand, since SCN2A muta-
tions are linked to various forms of epilepsy, a late onset
cannot be ruled out either [33].
This participant demonstrated with significant sensory
reactivity issues. Most sensory reactivity differences were
reported on oral, tactile, multisensory, vestibular, and
visual processing followed, less markedly, by auditory
processing. The participant fell into the ‘sensation seeker’
and ‘poor registration’ category. Further, the participant
seemed to be overwhelmed by some aspects of the
environment such as touch (washing face, wool clothes),
while being under-responsive to other aspects of the
environment (bruises, cuts). Pain related perception is
processed via nociceptors (e.g., unmyelinated C fibres)
whereas light touch is processed by cutaneous receptors
(e.g. Meissner’s corpuscles or Merkel discs) [34]. Exam-
ining sensory reactivity in cases with ASD and SCN2A
mutations is important because comorbid sensory
symptoms often compromise an individual’s and family’s
quality of life [35]. Sensory over-reactivity has also been
linked to high rates of anxiety in individuals with ASD
[33,36,37].
Future research is needed to confirm the phenotypes
observed in the current case report in more cases with
SCN2A mutations. Identifying a robust phenotype for
SCN2A cases will help to reduce the phenotypic hetero-
geneity seen in individuals with ASD.
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